ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 25 filers reported holding ENZYMOTEC LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $610,000 | +79.4% | 75,338 | +94.8% | 0.00% | 0.0% |
| Q1 2017 | $340,000 | -3.4% | 38,672 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $352,000 | +43.1% | 38,672 | +9.9% | 0.00% | 0.0% |
| Q3 2016 | $246,000 | -16.3% | 35,187 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $294,000 | +37.4% | 35,187 | +48.6% | 0.00% | +100.0% |
| Q1 2016 | $214,000 | +55.1% | 23,686 | +67.9% | 0.00% | 0.0% |
| Q4 2015 | $138,000 | +66.3% | 14,110 | +53.1% | 0.00% | 0.0% |
| Q3 2015 | $83,000 | – | 9,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 327,962 | $7,222,000 | 2.32% |
| Matterhorn Capital Management, LLC | 123,706 | $2,708,000 | 1.25% |
| ALYDAR PARTNERS LLC | 311,350 | $6,856,000 | 0.68% |
| Perceptive Advisors | 214,219 | $4,717,000 | 0.50% |
| Paulson & Co. | 4,271,230 | $94,052,000 | 0.46% |
| Visium Asset Management, LP | 1,140,000 | $25,103,000 | 0.41% |
| FRIESS ASSOCIATES LLC | 122,500 | $2,697,000 | 0.21% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 263,653 | $5,806,000 | 0.18% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 167,125 | $3,680,000 | 0.14% |
| Alyeska Investment Group, L.P. | 185,533 | $4,085,000 | 0.11% |